Breast and Ovarian Cancer Genomics
41 – 50 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Ovarian Carcinoma - Early Detection and Prognostication
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
(2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
-
Mark
Interferon Alpha-Inducible Protein 27 Expression Is Linked to Disease Severity in Chronic Infection of Both HIV-1 and HIV-2
- Contribution to journal › Article
- 2021
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
(2021)
- Contribution to conference › Poster
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
- Contribution to journal › Article
-
Mark
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
- Contribution to journal › Article
